- Getinge AB (publ) press release (OTCPK:GNGBF): Q4 Non-GAAP EPS of SEK 5.28.
- Revenue of SEK 11.07B (+11.7% Y/Y).
- Adjusted gross margin was 50.6%.
- Adjusted EBITA amounted to SEK 2,143M.
- Free cash flow amounted to SEK 1,693M.
- The company said that it has initiated the process with the intention of discontinuing Surgical Perfusion.
- Outlook 2025: Net sales for 2025 are expected to increase by 2–5% organically. (No guidance previously provided for 2025).
